Clinical Trials Directory

Trials / Completed

CompletedNCT04083859

Digital Outreach Intervention for Lung Cancer Screening

A Pragmatic Randomized-Controlled Trial of a Digital Outreach Intervention for Lung Cancer Screening: mPATH-Lung (Mobile Patient Technology for Health-Lung)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26,998 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
50 Years – 77 Years
Healthy volunteers
Accepted

Summary

mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews. This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.

Detailed description

Primary Objective: Determine the effectiveness of mPATH-Lung on receipt of LCS in a randomized pragmatic clinical trial of 1318 patients recruited from two large health networks, Wake Forest Baptist Health and the University of North Carolina at Chapel Hill. Secondary Objectives: * Elucidate the drivers of patients' decisions to receive or forgo LCS through a values clarification exercise embedded within mPATH-Lung and supplemental semi-structured interviews of at least 50 patients. * Assess several critical implementation outcomes (reach, acceptability, and appropriateness) to inform the sustainability and scalability of mPATH-Lung across diverse primary care settings

Conditions

Interventions

TypeNameDescription
OTHERmPATH-LungA web-based program that determines patients eligibility for lung cancer screening (LCS), informs them of LCS, presents them with personalized risk-benefit information, helps them make a screening decision, and helps them schedule a LCS clinic appointment.
OTHERLung health videoWeb-based video about guideline recommended exercise for lung health

Timeline

Start date
2022-01-01
Primary completion
2023-09-30
Completion
2024-09-30
First posted
2019-09-10
Last updated
2025-06-25
Results posted
2025-01-16

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04083859. Inclusion in this directory is not an endorsement.